CIK 0000812796 · Non-accelerated filer<br>Smaller reporting company
SOLIGENIX, INC.
Sign in to watch- Ticker
- SNGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 411505029
- Phone
- 609-538-8200
- Business address
- 29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
- Former names
- SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
- S-3 Offering Registration Statement
- 10QSB Other 10QSB
- SC 13D/A Stake Beneficial Ownership Report
- DEF 14A Proxy Proxy Statement
- 10KSB Other 10KSB
- 10-Q Report Quarterly Report
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10QSB Other 10QSB
- S-2/A Other S-2/A
- 10KSB/A Other 10KSB/A
- 8-A12B/A Other Registration Statement
- 8-A12B Other Registration of Securities
- 10KSB/A Other 10KSB/A
- S-2/A Other S-2/A
- S-2/A Other S-2/A
- 10QSB Other 10QSB
- DEF 14A Proxy Proxy Statement
- 10KSB/A Other 10KSB/A
- S-2/A Other S-2/A
- PRE 14A Proxy Proxy Statement (Preliminary)
Page 69 of 72 · 1,429 filings